Metastatic Colorectal Cancer Clinical Trials in Guangzhou, Guangdong
4 recruitingGuangzhou, Guangdong, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Sun Yat-sen University198 enrolled3 locationsNCT05959356
Recruiting
Phase 2Phase 3
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
Metastatic Colorectal Cancer
Shanghai Henlius Biotech568 enrolled5 locationsNCT04547166
Recruiting
Phase 3
A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis
Metastatic Colorectal Cancer
Yuhong Li142 enrolled1 locationNCT02102789
Recruiting
Phase 2
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
Metastatic Colorectal Cancer
Sun Yat-sen University54 enrolled1 locationNCT05962502